2022

Journey Medical Capital Markets Advisory Ending May 22

SCYNEXIS Announces Closing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

Scientific Industries Secures New Funding to Accelerate Growth of Its Bioprocessing Business

Relativity Acquisition Corp. Announces Closing of $143.75 Million Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option

Western Acquisition Ventures Corp. Prices $100 Million Initial Public Offering

Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering

AnaBios Closes Financing with Ampersand Capital Partners

RH B Dyson May 22

CNS

Scynexis